|
|
|
|
|
|
Deciding whether a drug candidate should be developed as part of a combination or not should hinge on available evidence and a company’s therapeutic hypothesis.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Examining The New Look For Biotech
|
According to a recent episode of Citeline’s podcast series, “Small Biotechs, Big Decisions,” biotech is developing a new look that is leaner and savvier when it comes to working with partners.
|
|
|
|
|
| Connect With Life Science Leader: |
|
|
|
|